2003
DOI: 10.1081/iph-120020472
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Anti-CD3 and Interleukin-2 Stimulated T Lymphocyte Proliferation by Peptidomimetic Opioid Compound

Abstract: In continuation to our earlier studies with peptidomimetic opioid compounds, we have further investigated immunosuppressive properties of one of our peptidomimetic compound (Tyr-NH-CH2-CH2-O-Phe-NH2) using peripheral blood mononuclear cells (PBMCs) of healthy volunteers. Peptidomimetic compound was evaluated for its effect on anti-CD3 and recombinant human interleukin-2 (rhIL-2) stimulated lymphocyte proliferation in vitro and lipopolysaccharide (LPS) induced activation of mitogen activated protein kinase (MAP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2003
2003
2004
2004

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…The data indicate that in vitro culture resulted in preferential expansion of certain clones from a relatively small number of T cells in the original tumor samples. In in vitro culture conditions, anti-CD3 Ab (OKT3) and IL-2 were used to drive nonspecific T cell proliferation (16). Therefore, T cell populations with a high capacity for cell division expanded preferentially during the TIL generation culture.…”
Section: Discussionmentioning
confidence: 99%
“…The data indicate that in vitro culture resulted in preferential expansion of certain clones from a relatively small number of T cells in the original tumor samples. In in vitro culture conditions, anti-CD3 Ab (OKT3) and IL-2 were used to drive nonspecific T cell proliferation (16). Therefore, T cell populations with a high capacity for cell division expanded preferentially during the TIL generation culture.…”
Section: Discussionmentioning
confidence: 99%